Combined hepatoprotective and antidepressant effects of resveratrol in an acute model of depression

Serafini, 2012, Neuroplasticity and major depression, the role of modern antidepressant drugs, World J Psychiatry, 2, 49, 10.5498/wjp.v2.i3.49 Mahesh, 2012, Antidepressant potential of 5-HT3 receptor antagonist, N-n-propyl-3-ethoxyquinoxaline-2-carboxamide (6n), J Young Pharm, 4, 235, 10.4103/0975-1483.104367 Mahaffey, 2010, Fluoxetine acts as an antagonist at 5-HT2C receptors in the Crayfish neuromuscular junction, Pioneering Neurosci, 11, 27 Inkielewicz-Stępniak, 2011, Impact of fluoxetine on liver damage in rats, Pharmacol Rep, 63, 441, 10.1016/S1734-1140(11)70510-2 Ogle, 2013, Potential of treating age-related depression and cognitive decline with nutraceutical approaches: a mini-review, Gerontology, 59, 23, 10.1159/000342208 Baur, 2006, Therapeutic potential of resveratrol: the in vivo evidence, Nat Rev Drug Discov, 5, 493, 10.1038/nrd2060 Chen, 2011, Resveratrol inhibits cell differentiation in 3T3-L1 adipocytes via activation of AMPK, Can J Physiol Pharmacol, 89, 793 Timmers, 2012, The journey of resveratrol from yeast to human, Aging, 4, 146, 10.18632/aging.100445 Vang, 2011, What is new for an old molecule? Systematic review and recommendations on the use of resveratrol, PLoS One, 6, e19881, 10.1371/journal.pone.0019881 Ara, 2005, Protective effect of resveratrol against oxidative stress in cholestasis, J Surg Res, 127, 112, 10.1016/j.jss.2005.01.024 Cerný, 2009, Effects of resveratrol pretreatment on tert-butylhydroperoxide induced hepatocyte toxicity in immobilized perifused hepatocytes: involvement of inducible nitric oxide synthase and hemoxygenase-1, Nitric Oxide, 20, 1, 10.1016/j.niox.2008.08.006 Farghali, 2009, Resveratrol attenuates lipopolysaccharide-induced hepatitis in d-galactosamine sensitized rats: role of nitric oxide synthase 2 and heme oxygenase-1, Nitric Oxide, 21, 216, 10.1016/j.niox.2009.09.004 Farghali, 2013, Resveratrol and related compounds as antioxidants with an allosteric mechanism of action in epigenetic drug targets, Physiol Res, 62, 1, 10.33549/physiolres.932434 Chen, 2007, Chinese herbs and herbal extracts for neuroprotection of dopaminergic neurons and potential therapeutic treatment of Parkinson’s disease, CNS Neurol Disord Drug Targets, 6, 273, 10.2174/187152707781387288 Kumar, 2007, Neuroprotective effects of resveratrol against intracerebroventricular colchicine induced cognitive impairment and oxidative stress in rats, Pharmacology, 79, 17, 10.1159/000097511 Ranney, 2009, Resveratrol protects spatial learning in middle-aged C57BL/6 mice from effects of ethanol, Behav Pharmacol, 20, 330, 10.1097/FBP.0b013e32832f0193 Xu, 2010, Antidepressant-like effect of trans-resveratrol: Involvement of serotonin and noradrenaline system, Eur Neuropsychopharmacol, 20, 405, 10.1016/j.euroneuro.2010.02.013 Huang, 2004, Brain IL-1 beta was involved in reserpine-induced behavioral depression in rats, Acta Pharmacol Sin, 25, 293 Bellés, 2005, Combined action of uranium and stress in the rat: I. Behavioral effects, Toxicol Lett, 158, 176, 10.1016/j.toxlet.2005.03.011 Kim, 2005, Antidepressant effect of Chaihu-Shugan-San extract and its constituents in rat models of depression, Life Sci, 76, 1297, 10.1016/j.lfs.2004.10.022 Pruus, 2002, Role of 5-HT1A receptors in the mediation of acute citalopram effects. A 8-OH-DPAT challenge study, Prog Neuropsychopharmacol Biol Psychiat, 26, 227, 10.1016/S0278-5846(01)00253-6 Porsolt, 1977, Depression: a new animal model sensitive to antidepressant treatments, Nature, 266, 730, 10.1038/266730a0 Pagel, 2000, High-performance liquid chromatographic separation and measurement of various biogenic compounds possibly involved in the pathomechanism of Parkinson’s disease, J Chromatogr B, 746, 297, 10.1016/S0378-4347(00)00348-0 Mansour, 2002, Effects of thymoquinone on antioxidant enzyme activities, lipid peroxidation and DT-diaphorase in different tissues of mice: a possible mechanism of action, Cell Biochem Funct, 19, 1 Ruiz-Larea, 1994, Antioxidant effects of estradiol and 2-hydroxyestradiol on iron-induced lipid peroxidation of rat liver microsomes, Steroids, 59, 383, 10.1016/0039-128X(94)90006-X Ellman, 1959, Tissue sulfhydryl groups, Arch Biochem Biophys, 82, 70, 10.1016/0003-9861(59)90090-6 Bulaj, 1998, Ionization-reactivity relationships for cysteine thiols in polypeptides, Biochemistry, 37, 8965, 10.1021/bi973101r Kumar, 1999, Antidepressant activity of Indian hypericum perforatum Linn in rodents, Indian J Exp Biol, 37, 1171 Kim, 2001, Characterization of antidepressant-like effects of p-synephrine stereoisomers, Naunyn Schmiedebergs Arch Pharmacol, 364, 21, 10.1007/s002100100416 O’Donnell, 2007, The behavioral actions of lithium in rodent models: leads to develop novel therapeutics, Neurosci Biobehav Rev, 31, 932, 10.1016/j.neubiorev.2007.04.002 Leith, 1980, Effects of chronic amphetamine or reserpine on self stimulation responding: animal model of depression?, Psychopharmacol, 72, 9, 10.1007/BF00433801 Minor, 2003, Cytokine–purine interactions in behavioral depression in rats, Integr Physiol Behav Sci, 38, 189, 10.1007/BF02688853 Rojas-Corrales, 2004, Antidepressant-like effect of tramadol and its enantiomers in reserpinized mice: comparative study with desipramine, fluvoxamine, venlafaxine and opiates, J Psychopharmacol, 18, 404, 10.1177/026988110401800305 Qingjun, 2003, Adenosine A2a receptor mediates reserpine-induced depression in rats, Acta Psychol Sin, 35, 106 Dhingra, 2007, Evaluation of the antidepressant-like activity of Convolvulus pluricaulis choisy in the mouse forced swim and tail suspension tests, Med Sci Monit, 13, 155 Tadaiesky, 2006, Different effects of 7-nitroindazole in reserpine-induced hypolocomotion in two strains of mice, Eur J Pharmacol, 535, 199, 10.1016/j.ejphar.2006.02.004 Woode, 2009, Antidepressant-like effects of an ethanolic extract of Sphenocentrum jollyanum pierre roots in Mice, Int J Pharmacol, 5, 22, 10.3923/ijp.2009.22.29 Abílio, 2002, Effects of melatonin on orofacial movements in rats, Psychopharmacol, 161, 340, 10.1007/s00213-002-1081-7 Naidu, 2004, Reversal of reserpine-induced orofacial dyskinesia and cognitive dysfunction by quercetin, Pharmacology, 70, 59, 10.1159/000074669 Naidu, 2006, Effect of Withania somnifera root extract on reserpine-induced orofacial dyskinesia and cognitive dysfunction, Phytother Res, 20, 140, 10.1002/ptr.1823 Wang, 2013, Antidepressant-like activity of resveratrol treatment in the forced swim test and tail suspension test in mice: the HPA axis, BDNF expression and phosphorylation of ERK, Pharmacol Biochem Behav, 112, 104, 10.1016/j.pbb.2013.10.007 Yáñez, 2006, Inhibitory effects of cis- and trans-resveratrol on noradrenaline and 5-hydroxytryptamine uptake and on monoamine oxidase activity, Biochem Biophys Res Commun, 344, 688, 10.1016/j.bbrc.2006.03.190 Beasley, 2000, Efficacy, adverse events, and treatment discontinuations in fluoxetine clinical studies of major depression: a meta-analysis of the 20 mg/day dose, J Clin Psychiatry, 61, 722, 10.4088/JCP.v61n1003 Thompson, 2000, Spontaneous hydrolysis of 4-trifluoromethylphenol to a quinone methide and subsequent protein alkylation, Chem-Biol Interact, 126, 1, 10.1016/S0009-2797(99)00162-3 Zafir, 2007, Antioxidant potential of fluoxetine in comparison to Curcuma longa in restraint-stressed, Eur J Pharmacol, 572, 23, 10.1016/j.ejphar.2007.05.062 Adachi, 2007, Serum glutathione S-transferase in experimental liver damage in rats, J Gastroenterol, 16, 129 Bishayee, 2010, Resveratrol and liver disease: from bench to bedside and community, Liver Int, 30, 1103, 10.1111/j.1478-3231.2010.02295.x Hamadi, 2012, Ameliorative effects of resveratrol on liver injury in streptozotocin-induced diabetic rats, J Biochem Mol Toxicol, 26, 384, 10.1002/jbt.21432 Lee, 2010, Resveratrol inhibits dimethylnitrosamine-induced hepatic fibrosis in rats, Arch Pharm Res, 33, 925, 10.1007/s12272-010-0616-4